Health investors get selective as US markets churn into 2019
Bloomberg Healthcare investors may have to be a bit more selective than they’re used to in 2019. With US health stocks poised to wrap up their second straight year of outperforming the broader market, the focus on hunting for innovation and next year’s winners is even more in vogue after recent market volatility. Small- to mid-cap biotechnology darlings that saw ...
Read More »